Perceptive Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Perceptive Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-150,875	Closed	-$13.9M	–	125
2018 Q2	$13.9M	Sell	150,875 -55,430	-27%	-$5.38M	0.36%	53
2018 Q1	$20.6M	Hold	206,305	–	–	0.58%	43
2017 Q4	$19.3M	Sell	206,305 -100	-0%	-$9.46K	0.64%	42
2017 Q3	$21M	Sell	206,405 -20,000	-9%	-$1.75M	0.81%	31
2017 Q2	$17.3M	Sell	226,405 -45,000	-17%	-$3.78M	0.87%	34
2017 Q1	$23.4M	Sell	271,405 -33,126	-11%	-$2.39M	1.33%	24
2016 Q4	$20.6M	Buy	+304,531	New	+$18.7M	1.47%	19
2015 Q3	–	Sell	-20,000	Closed	-$1.03M	–	166
2015 Q2	$1.03M	Buy	+20,000	New	+$1.06M	0.06%	118

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Perceptive Advisors's LKFT Position: Q3 2018 in Review

Perceptive Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2018, closing a stake of 150,875 shares — an estimated $13.9M sold.

Perceptive Advisors first reported a position in LKFT in Q2 2015 and held it in 8 quarters. The position peaked at $23.4M in Q1 2017. 92 funds tracked by Wall St. Rank hold LKFT as of Q3 2018.

Perceptive Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2018 after selling out during the quarter.
Perceptive Advisors sold 150,875 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2018, an estimated $13.9M.
Perceptive Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 8 quarters.
Perceptive Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $23.4M in Q1 2017.
92 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2018.

Based on Perceptive Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.